Theralase Technologies Inc. TLTFF
0.13 USD -0.01 (-7.14%)
At closeNov 5, 2026, 4:00 PM EST
0.1497 Day range 0.1497
0.10 52-week range 0.31
- YTD
- +8.33%
- 1 year
- -13.33%
- Market cap
- 40.36M
- EPS (ttm)
- -0.01
- YTD return
- +8.33%
- 1-year return
- -13.33%
- Volume
- 5.00K
- Avg volume
- 136.99K
- Open
- 0.1497
- Previous close
- 0.14
- Day's range
- 0.1497 – 0.1497
- 52-week range
- 0.10 – 0.31
5D +0.0114 (+8.24%)
News
Theralase Provides Bladder Cancer Clinical Study Update 
Theralase(R) to Present at ThinkEquity Conference 
Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements 
Theralase(R) Releases Q2 2026 Financial Statements 
Theralase(R) Closes C$3.6 Million Brokered Financing 
Theralase(R) Announces $5 Million Brokered LIFE Offering 
Theralase(R) Grants Stock Options 
Theralase(R) Engages Global One Media to Expand Global Investor Awareness 
Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus 
Theralase(R) Lists Warrants on the TSXV
Your note
Sign in to keep a note on TLTFF — it syncs with the Stock Master app.